EnerSys to acquire Ultralife in $320m all-cash defence power deal

EnerSys will pay $16 per share for Ultralife Corporation, a 166% premium, to build out its mission-critical defence power platform.

A modern conference room features a long, polished wooden table surrounded by black leather chairs, bathed in natural light from expansive windows offering a high-rise view of a city skyline, numerous skyscrapers, and a body of water.

EnerSys has agreed to acquire Ultralife Corporation (NASDAQ: ULBI) in an all-cash transaction valued at approximately $320 million, including the assumption of net debt. Under the terms of the merger agreement, Ultralife shareholders will receive $16.00 per share, representing a 166% premium to the company's closing price on 26 October 2026. Both boards have unanimously approved the deal, and EnerSys says it intends to fund the transaction from cash on hand, with no financing contingency attached.

The transaction is expected to close in the first quarter of 2027, subject to customary conditions including a majority tender of Ultralife shares and receipt of regulatory approvals. Upon completion, Ultralife's common stock will be delisted.

The deal

Ultralife, headquartered in Newark, New York, operates two business segments: Battery and Energy Products, and Communications Systems. It serves defence, medical, oil and gas, and industrial customers across North America, Europe and Asia. EnerSys, a larger NYSE-listed stored-energy group, serves communications networks, data centres, aerospace and defence clients in more than 100 countries.

EnerSys frames the rationale around three strategic goals: deepening its defence power portfolio, adding Ultralife's multi-chemistry battery capabilities and purpose-built manufacturing capacity, and broadening a product portfolio that is compliant with Foreign Entity of Concern (FEOC) requirements for US Department of Defence and allied-nation customers. FEOC compliance has become an increasingly significant procurement criterion as Washington moves to exclude Chinese-manufactured battery components from defence supply chains.

Shawn O'Connell, president and chief executive of EnerSys, said the acquisition "directly advances our strategy to build a broader, more differentiated defence power platform" and would better position the combined group to support allied forces with "leading-edge, cost-effective technologies for the increasingly electrified battlefield of the future."

Michael Manna, president and chief executive of Ultralife, described the deal as delivering "substantial and certain cash value" to shareholders while opening growth opportunities for employees and the combined business.

Market context

The global defence battery and power-electronics market has attracted sustained consolidation pressure as military procurement agencies accelerate electrification of platforms spanning soldier-worn systems, unmanned aerial vehicles, counter-drone systems and autonomous ground vehicles. EnerSys itself has been an active acquirer in recent periods, and this transaction follows that pattern of building scale in specialist power rather than competing head-on in the broader commercial energy-storage market.

FEOC compliance is emerging as a structural filter in US and allied procurement. Suppliers that can demonstrate full-stack domestic or allied-nation production, from cell chemistry through to finished system integration, are likely to command a durable pricing premium as defence budgets shift. Ultralife's existing security clearances and environmental permits at its manufacturing sites are cited in the release as a specific asset; replicating that permitted capacity from scratch would carry both time and regulatory cost for any competitor.

The 166% acquisition premium is a notable signal of strategic scarcity value. For context, defence-focused power and energy-storage targets of comparable scale are not numerous, and EnerSys appears to have moved decisively to pre-empt competing interest. Regulatory scrutiny is likely to focus on the standard CFIUS and antitrust reviews rather than sector-specific concerns, given that both companies are US-domiciled and the combination does not create an obvious monopoly position.